Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Tzu Tai

Showing results (201-210 of 211) with videos related to

Pageof 22
Sort By:
Nature Communications|August 25, 2019
Genomic landscape and chronological reconstruction of driver events in multiple myelomaFrancesco Maura, Niccoló Bolli, Nicos Angelopoulos, et al.
Blood Cancer Journal|February 6, 2023
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myelomaKeiji Kurata, Anna James-Bott, Mark A Tye, et al.
Nature Communications|June 15, 2022
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomesMark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, et al.
Blood Cancer Journal|January 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myelomaKeiji Kurata, Anna James-Bott, Mark A Tye, et al.
Blood Cancer Discovery|July 14, 2021
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple MyelomaHiroto Ohguchi, Paul M C Park, Tingjian Wang, et al.
Blood|February 8, 2022
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myelomaGeorgina S F Anderson, Jose Ballester-Beltran, George Giotopoulos, et al.
European Journal of Haematology|May 19, 2020
IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patientsXue-Han Mao, Jun-Ling Zhuang, Duo-Duo Zhao, et al.
Blood|September 20, 2022
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growthEugenio Morelli, Mariateresa Fulciniti, Mehmet K Samur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2020
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease ProgressionMark Bustoros, Romanos Sklavenitis-Pistofidis, Jihye Park, et al.
Nature Communications|January 17, 2014
Heterogeneity of genomic evolution and mutational profiles in multiple myelomaNiccolo Bolli, Hervé Avet-Loiseau, David C Wedge, et al.
Pageof 22

Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
Nature Communications|August 25, 2019
Genomic landscape and chronological reconstruction of driver events in multiple myelomaFrancesco Maura, Niccoló Bolli, Nicos Angelopoulos, et al.
Blood Cancer Journal|February 6, 2023
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myelomaKeiji Kurata, Anna James-Bott, Mark A Tye, et al.
Nature Communications|June 15, 2022
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomesMark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, et al.
Blood Cancer Journal|January 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myelomaKeiji Kurata, Anna James-Bott, Mark A Tye, et al.
Blood Cancer Discovery|July 14, 2021
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple MyelomaHiroto Ohguchi, Paul M C Park, Tingjian Wang, et al.
Blood|February 8, 2022
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myelomaGeorgina S F Anderson, Jose Ballester-Beltran, George Giotopoulos, et al.
European Journal of Haematology|May 19, 2020
IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patientsXue-Han Mao, Jun-Ling Zhuang, Duo-Duo Zhao, et al.
Blood|September 20, 2022
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growthEugenio Morelli, Mariateresa Fulciniti, Mehmet K Samur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2020
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease ProgressionMark Bustoros, Romanos Sklavenitis-Pistofidis, Jihye Park, et al.
Nature Communications|January 17, 2014
Heterogeneity of genomic evolution and mutational profiles in multiple myelomaNiccolo Bolli, Hervé Avet-Loiseau, David C Wedge, et al.
Pageof 22